The current valuation score of Alector Inc is 7.04, ranking 223 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.27, which is -43.32% below the recent high of -0.72 and -378.85% above the recent low of -6.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.